Komori
Nitto Denko (6988) · TargetAchieved

Medium-Term Management Plan “Jitsugen-2019”

First written in FY2017. 1 of 5 entries say "Reframed", first in FY2018. Latest entry: FY2023.

5entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017ReframedFY2018 – FY2019OtherFY20212017: 120172018: 120182019: 120192020: 020202021: 120212022: 020222023: 12023
Same theme, other companies
Achieving the Medium-Term Management PlanA theme 150 companies write about · 8 as a headwind · 153 as a tailwind

Nitto Denko moved to the "Worse" side of this theme in 2018, 4 years before the typical company in this theme (2022).

21 other companies' latest entry also says "Achieved".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 150 companies compared. The sentences above are computed from all 150.
Full recordFilings, disclosures and news, newest first
  1. FY2023AchievedAnnual report

    「The group achieved one year ahead of schedule the management targets it had set for the end of FY2023: revenue of ¥920,000 million, operating profit of ¥140,000 million, an operating margin of 15%, and ROE (profit attributable to owners of the parent divided by equity attributable to owners of the parent) of 12%.」

    The disclosure states that the financial targets of the previous medium-term management plan, Nitto Beyond 2023, were achieved one year ahead of schedule.
  2. FY2021Failure to meet the medium-term plan's numerical targets and transition to the next planAnnual report

    「Under the group's medium-term management plan "Jitsugen-2020," covering FY2018 through FY2020, the group had set targets of revenue of ¥1 trillion and operating profit of ¥175 billion in FY2020. However, the business environment changed significantly due to various factors in Japan and overseas, and the targets were not achieved. The company plans to announce a new medium-term management plan covering FY2021 through FY2023 during the current fiscal year and aims for further growth under a new growth strategy.」

    The company explicitly stated that Jitsugen-2020's performance targets were not achieved and indicated plans to transition to a new medium-term management plan covering FY2021 through FY2023.
  3. FY2019SoftenedAnnual report

    「The business environment has changed significantly, requiring a review of the assumptions. While the original performance targets will remain as desired levels to achieve, the company will work to rebuild its business foundation so that it can generate stable operating profit of ¥100 billion by around 2021.」

    While retaining Jitsugen-2020's original performance targets as desired levels to achieve, the company shifted its focus, in response to changes in the business environment, to rebuilding the business foundation around stable operating profit of ¥100 billion.
  4. FY2018ReframedAnnual report

    「Following the results for the year, the new medium-term management plan "Jitsugen-2020," covering the three years from FY2018 through FY2020 and updated on a rolling basis, sets higher group-wide targets of revenue of ¥1 trillion and operating profit of ¥175 billion in FY2020.」

    The company rolled forward Jitsugen-2019, launched in FY2017, and updated the plan to Jitsugen-2020, covering FY2018 through FY2020.
  5. FY2017First statedAnnual report

    「As the group approaches its 100th anniversary in October 2018, it launched the three-year medium-term management plan "Jitsugen-2019" in FY2017, with a view to growth beyond this milestone, and will focus on the following 3 priorities.」

    The company launched a three-year medium-term management plan in FY2017, focusing on restructuring existing businesses, pursuing a growth strategy and strengthening the management foundation.
Moved together

"Expansion of the Contract Synthesis Business for Nucleic Acid Medicines" moved the same way as this thread, in the same document, in 2 of its 5 moves.

222222★123456
  1. ★This thread
  2. 1Expansion of the Contract Synthesis Business for Nucleic Acid Medicines2×
  3. 2Global Economic Fluctuations and Foreign Exchange Risk2×
  4. 3Supply, Demand and Price Fluctuations in the LCD and Touch-Panel Markets2×
  5. 4Business Portfolio Transformation2×
  6. 5Information System Failures and Information Leaks2×
  7. 6Changes in Defined Benefit Liability2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Nitto Denko's next results are scheduled for 2026-10-27. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.